Marcus Schindler
Chief Tech/Sci/R&D Officer presso NOVO NORDISK A/S
Posizioni attive di Marcus Schindler
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NOVO NORDISK A/S | Chief Tech/Sci/R&D Officer | 01/03/2021 | - |
| Corporate Officer/Principal | 01/01/2018 | 01/03/2021 |
Storia della carriera di Marcus Schindler
Precedenti posizioni note di Marcus Schindler
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INNATE PHARMA | Director/Board Member | 01/01/2018 | 28/05/2021 |
| The Oxford | Chief Tech/Sci/R&D Officer | - | 29/02/2008 |
Prosidion Ltd.
 Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Prosidion Ltd. manufactures products for treatment of metabolic diseases such as diabetes and obesity. The company's products include oral inhibitors of dipeptidyl peptidase, glycogen phosphorylase inhibitor and glucokinase activator. It was founded in 2003 and is headquartered in Oxford, UK | Chief Tech/Sci/R&D Officer | - | - |
AstraZeneca A/S /Denmark/
 AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - | - |
Formazione di Marcus Schindler
| University of Cambridge | Doctorate Degree |
| University of Gottingen | Graduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 4 |
| Danimarca | 3 |
| Francia | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| INNATE PHARMA | Health Technology |
| Aziende private | 3 |
|---|---|
| The Oxford | Consumer Services |
Prosidion Ltd.
Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Prosidion Ltd. manufactures products for treatment of metabolic diseases such as diabetes and obesity. The company's products include oral inhibitors of dipeptidyl peptidase, glycogen phosphorylase inhibitor and glucokinase activator. It was founded in 2003 and is headquartered in Oxford, UK | Health Technology |
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Marcus Schindler
- Esperienza
